Literature DB >> 21336991

Immunogenicity of orally administrated recombinant Lactobacillus casei Zhang expressing Cryptosporidium parvum surface adhesion protein P23 in mice.

Rihua Xu, Honglin Jia, Mohamad Alaa Terkawi, Xuenan Xuan, Heping Zhang.   

Abstract

Cryptosporidium parvum, an intestinal apicomplexan parasite, is a significant cause of diarrheal diseases in both humans and animals. What is more, there is no promising strategy for controlling cryptosporidiosis. In this study, the P23 immunodominant surface protein of C. parvum sporozoites was stably expressed in the Lactobacillus casei Zhang strain and its immunogenicity was evaluated in a mouse model. The molecular weight (23 kDa) and immunogenicity of p23 gene expressed by L. casei Zhang were similar to that of the native P23 protein. Oral immunization with control L. casei Zhang and recombinant L. casei Zhang-p23 activated the mucosal immune system to elicit serum immunoglobulin G (IgG) and mucosal IgA in mice. Furthermore, the expression of cytokines such as IL-4, IL-6, and IFN-γ in splenocytes of mice was detected by real-time PCR after oral immunization. P23-specific immunocyte activation was also verified. These findings indicate that the live L. casei Zhang vector may be a new tool for the production of mucosal vaccines against cryptosporidiosis in animals.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21336991     DOI: 10.1007/s00284-011-9894-4

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  40 in total

1.  Differential expression of Cryptosporidium parvum genes encoding sporozoite surface antigens in infected HCT-8 host cells.

Authors:  Vera Jakobi; Franz Petry
Journal:  Microbes Infect       Date:  2006-06-02       Impact factor: 2.700

Review 2.  Human cryptosporidiosis: epidemiology, transmission, clinical disease, treatment, and diagnosis.

Authors:  J K Griffiths
Journal:  Adv Parasitol       Date:  1998       Impact factor: 3.870

3.  Protection of calves against cryptosporidiosis with immune bovine colostrum induced by a Cryptosporidium parvum recombinant protein.

Authors:  L E Perryman; S J Kapil; M L Jones; E L Hunt
Journal:  Vaccine       Date:  1999-04-23       Impact factor: 3.641

4.  Detection of mucosally delivered antibody to Cryptosporidium parvum p23 in infected calves.

Authors:  C R Wyatt; L E Perryman
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

5.  Molecular characterization of Cryptosporidium spp. from HIV infected patients from an urban area of Brazil.

Authors:  Patrícia de Lucca; Elizabeth Natal De Gaspari; Lígia M Bozzoli; Mikaela Renata Funada; Sheila Oliveira de Souza Silva; Wilma Iuliano; Rodrigo Martins Soares
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2009 Oct-Dec       Impact factor: 1.846

6.  Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV Env.

Authors:  Ke-Qin Xin; Yuka Hoshino; Yoshihiko Toda; Shizunobu Igimi; Yoshitsugu Kojima; Nao Jounai; Kenji Ohba; Akira Kushiro; Mayumi Kiwaki; Kenji Hamajima; Dennis Klinman; Kenji Okuda
Journal:  Blood       Date:  2003-03-20       Impact factor: 22.113

7.  Recombinant Lactobacillus johnsonii as a mucosal vaccine delivery vehicle.

Authors:  Lorenz Scheppler; Monique Vogel; Adrian W Zuercher; Michael Zuercher; Jacques-Edouard Germond; Sylvia M Miescher; Beda M Stadler
Journal:  Vaccine       Date:  2002-07-26       Impact factor: 3.641

8.  Oral vaccination with the porcine rotavirus VP4 outer capsid protein expressed by Lactococcus lactis induces specific antibody production.

Authors:  Yi-jing Li; Guang-peng Ma; Gui-wei Li; Xin-yuan Qiao; Jun-wei Ge; Li-jie Tang; Min Liu; Li-wei Liu
Journal:  J Biomed Biotechnol       Date:  2010-06-06

Review 9.  Cryptosporidiosis in children in Sub-Saharan Africa: a lingering challenge.

Authors:  Siobhan M Mor; Saul Tzipori
Journal:  Clin Infect Dis       Date:  2008-10-01       Impact factor: 9.079

10.  Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum.

Authors:  C Grangette; H Müller-Alouf; D Goudercourt; M C Geoffroy; M Turneer; A Mercenier
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

View more
  5 in total

1.  Systemic antibody responses to the immunodominant p23 antigen and p23 polymorphisms in children with cryptosporidiosis in Bangladesh.

Authors:  Anoli J Borad; Geneve M Allison; David Wang; Sabeena Ahmed; Mohammad M Karim; Anne V Kane; Joy Moy; Patricia L Hibberd; Sitara Swarna Rao Ajjampur; Gagandeep Kang; Stephen B Calderwood; Edward T Ryan; Elena Naumova; Wasif A Khan; Honorine D Ward
Journal:  Am J Trop Med Hyg       Date:  2012-02       Impact factor: 2.345

2.  Systemic and Mucosal Immune Responses to Cryptosporidium-Vaccine Development.

Authors:  Jacob G Ludington; Honorine D Ward
Journal:  Curr Trop Med Rep       Date:  2015-09-01

Review 3.  Prospects for immunotherapy and vaccines against Cryptosporidium.

Authors:  Jan R Mead
Journal:  Hum Vaccin Immunother       Date:  2014-03-17       Impact factor: 3.452

Review 4.  Lessons Learned from Protective Immune Responses to Optimize Vaccines against Cryptosporidiosis.

Authors:  Maxime W Lemieux; Karine Sonzogni-Desautels; Momar Ndao
Journal:  Pathogens       Date:  2017-12-24

Review 5.  Probiotic-Based Vaccines May Provide Effective Protection against COVID-19 Acute Respiratory Disease.

Authors:  Sedigheh Taghinezhad-S; Amir Hossein Mohseni; Luis G Bermúdez-Humarán; Vincenzo Casolaro; Naima G Cortes-Perez; Hossein Keyvani; Jesus Simal-Gandara
Journal:  Vaccines (Basel)       Date:  2021-05-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.